Institutional Biosafety Commitee (IBC)

The function of the Institutional Biosafety Committee (IBC) is to ensure that research using recombinant or synthetic DNA, infectious agents, or select agents/toxins is carried out in conformity with federal guidelines. Questions regarding the IBC may be directed to Dr. John Singer,  207.581.2808,, Chair of the Committee.

IBC Membership: Current membership listing.

Policies and Procedures for Research Involving Recombinant or Synthetic Nucleic Acid Molecules or Infectious Agents (Word)  (Revised May 2017)

Request-Notification Regarding the Use of Recombinant DNA (Word) (print out and send to John Singer, Hitchner Hall)

Request to Use Class 2 or Higher Infectious Agents in Teaching or Research (Word) (print out and send to John Singer, Hitchner Hall)

Required Training:  All faculty, staff, and students involved with the use of recombinant DNA or infectious agents must complete training

Biosafety Checklist (Word) (recommended that BLS2 labs conduct a self-audit on a yearly basis)


Contact for Questions

Portrait of Paula PortalatinPaula Portalatin
Research Compliance Officer III
207.581.2657, 311 Alumni Hall


Portrait of Amanda AsheAmanda Ashe, CRA
Director of Research Compliance
207.581.1480, 310 Alumni Hall